Case Analysis Of Johnson & Johnson

Johnson & Johnson Company is a Pharmaceutical company all over the world. It was found in 1886 by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson. The company produced its first products in 1886 and incorporated in 1887. It became a public company in 1944, listed shares on the New York Stock Exchange with ticker tape code JNJ. Johnson & Johnson and The Company 's subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. Its subsidiaries have approximately 129,000 employees worldwide in 2015. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets. The business of Johnson & Johnson

Paragraph 5.7.10 a gain or loss on a financial asset measured at fair value through other comprehensive income in accordance with paragraph 4.1.2A should recognize in the other comprehensive income, except the impairment gains or losses and foreign exchange gains and losses until the financial asset is derecognized or reclassified. When the financial asset is derecognized the cumulative gain or loss previously recognized in another comprehensive income is reclassified from equity to profit or loss as a reclassification adjustment. If the financial asset is reclassified out of the fair value through other comprehensive income measurement category, the entity should account for the cumulative gain or loss that was previously recognized in other comprehensive